Uganda approves Covidex as a supportive treatment for COVID-19


Uganda’s National Drug Authority (NDA) has approved Covidex as a supportive treatment for viral infections including COVID-19 but not as a cure.

In a statement, NDA stated that after a record time of 14 days of engagements with the innovators and assessments of the product information, Covidex, has been notified to be sold in licensed drug outlets for supportive treatment in managing viral infections but not as a cure of COVID-19.

“After engagements, the innovators have removed unsubstantiated claims that the product treats and prevents COVID-19 and revised it to supportive treatment in the management of viral infections,” the statement read.

Covidex has been formulated from herbal plants that have been traditionally used to alleviate symptoms of several diseases.

To further support the efficacy of the drug for other uses, NDA has advised the manufacturer to conduct random controlled clinical trials which are the highest level of evidence to ascertain any claims of treatment.

Leave a Reply